At a glance
ClinicalIndex Comparison RecordN/ACompleted· 550 enrolled
Drug / intervention
HF Pressure Measurement Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
In Brief
A clinical study evaluating HF Pressure Measurement System for Heart Failure, Congestive. Completed, enrolled 550 participants across 1 site.
Detailed Summary
This is a prospective, multi-center, randomized, single-blind clinical trial conducted in the United States (US). The objective of the study is to evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Congestive
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedSep 2007
Primary CompletionMay 2010
Study CompletionNov 2014
TodayJul 2026
First PostedSep 19, 2007
Enrollment StartSep 1, 2007
Primary CompletionMay 1, 2010
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 18.8 years ago
Interventions
HF Pressure Measurement Systemdevice
A pressure sensor is intended to be implanted into the pulmonary artery at the time of Swan-Ganz catheterization.